Development of a doxycycline-inducible lentiviral plasmid with an instant regulatory feature

Plasmid

Volumn 72, Issue 1, 2014, Pages 29-35

  Yang, Tian ^a,b   Burrows, Christopher ^a   Park, Jeong Hyeon ^a  

^a MASSEY UNIVERSITY   (New Zealand)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bicistronic; Doxycycline; Inducible expression; Lentivirus; PPM1B; Tetracycline responsive element

Indexed keywords

COMPLEMENTARY DNA; DOXYCYCLINE; LENTIVIRUS VECTOR; TRANSACTIVATOR PROTEIN;

ARTICLE; AUTOREGULATION; CONTROLLED STUDY; EMBRYO; GENE; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LENTIVIRINAE; MOLECULAR CLONING; NONHUMAN; PPM1B GENE; PROMOTER REGION; PROTEIN BINDING; RTTA GENE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS TITRATION; BACTERIAL GENE; BIOSYNTHESIS; CYTOMEGALOVIRUS; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; HEK293 CELL LINE; PLASMID; TRANSCRIPTION INITIATION; VIRUS GENE;

CYTOMEGALOVIRUS; DOXYCYCLINE; GENE EXPRESSION REGULATION, VIRAL; GENES, BACTERIAL; GENES, VIRAL; HEK293 CELLS; HUMANS; LENTIVIRUS; PLASMIDS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; TRANSDUCTION, GENETIC;

EID: 84899869963     PISSN: 0147619X     EISSN: 10959890     Source Type: Journal    
DOI: 10.1016/j.plasmid.2014.04.001     Document Type: Article

References (28)

1. Arumugam P.I., et al. The 3' region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity. PLoS One 2009, 4:e6995.
2. Barde I., et al. Efficient control of gene expression in the hematopoietic system using a single Tet-On inducible lentiviral vector. Mol. Ther. 2006, 13:382-390.
3. Barkess G., West A.G. Chromatin insulator elements: establishing barriers to set heterochromatin boundaries. Epigenomics 2012, 4:67-80.
4. Beisel C., Paro R. Silencing chromatin: comparing modes and mechanisms. Nat. Rev. Genet. 2011, 12:123-135.
5. Benabdellah K., et al. Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines. PLoS One 2011, 6:e23734.
6. Centlivre M., et al. Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo. Gene Ther. 2010, 17:14-25.
7. Ellis B.L., et al. Creating higher titer lentivirus with caffeine. Hum. Gene Ther. 2011, 22:93-100.
8. Gallagher P.G., et al. An insulator with barrier-element activity promotes alpha-spectrin gene expression in erythroid cells. Blood 2009, 113:1547-1554.
9. Gallagher P.G., et al. Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis. J. Clin. Invest. 2010, 120:4453-4465.
10. Gasmi M., et al. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J. Virol. 1999, 73:1828-1834.
11. Gijsbers R., et al. LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol. Ther. 2010, 18:552-560.
12. Giry-Laterriere M., et al. Polyswitch lentivectors: "all-in-one" lentiviral vectors for drug-inducible gene expression, live selection, and recombination cloning. Hum. Gene Ther. 2011, 22:1255-1267.
13. Gould D.J., et al. A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications. Gene Ther. 2000, 7:2061-2070.
14. Goverdhana S., et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol. Ther. 2005, 12:189-211.
15. Heinz N., et al. Graded or threshold response of the tet-controlled gene expression: all depends on the concentration of the transactivator. BMC Biotechnol. 2013, 13:5.
16. Lammers T., Lavi S. Role of type 2C protein phosphatases in growth regulation and in cellular stress signaling. Crit. Rev. Biochem. Mol. Biol. 2007, 42:437-461.
17. Li M.J., et al. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol. Ther. 2005, 12:900-909.
18. Lorincz M.C., et al. Dynamic analysis of proviral induction and De Novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression. Mol. Cell Biol. 2000, 20:842-850.
19. Markusic D., et al. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res. 2005, 33:e63.
20. Mitta B., et al. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res. 2002, 30:e113.
21. Park J.H., et al. The GAS41-PP2Cbeta complex dephosphorylates p53 at serine 366 and regulates its stability. J. Biol. Chem. 2011, 286:10911-10917.
22. Recillas-Targa F., et al. Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc. Natl. Acad. Sci. USA 2002, 99:6883-6888.
23. Shockett P., et al. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 1995, 92:6522-6526.
24. Strathdee C.A., et al. Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene 1999, 229:21-29.
25. Vogel R., et al. A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. Hum. Gene Ther. 2004, 15:157-165.
26. Wallace J.A., Felsenfeld G. We gather together: insulators and genome organization. Curr. Opin. Genet. Dev. 2007, 17:400-407.
27. Watt F., Molloy P.L. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 1988, 2:1136-1143.
28. Zufferey R., et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 1998, 72:9873-9880.